Silverleafe Capital Partners LLC Takes Position in Tempus AI, Inc. (NASDAQ:TEM)

Silverleafe Capital Partners LLC purchased a new position in Tempus AI, Inc. (NASDAQ:TEM) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 15,782 shares of the company’s stock, valued at approximately $533,000.

A number of other hedge funds also recently bought and sold shares of the business. NEA Management Company LLC raised its stake in shares of Tempus AI by 17.8% during the 3rd quarter. NEA Management Company LLC now owns 5,385,979 shares of the company’s stock worth $304,846,000 after buying an additional 813,169 shares during the period. Novo Holdings A S purchased a new position in Tempus AI during the second quarter valued at $142,605,000. Revolution Growth Management Company Inc. acquired a new stake in shares of Tempus AI in the second quarter valued at about $128,133,000. ARK Investment Management LLC increased its stake in shares of Tempus AI by 355.0% during the third quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company’s stock worth $134,604,000 after purchasing an additional 1,855,459 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. raised its position in shares of Tempus AI by 1,591.2% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company’s stock worth $68,922,000 after purchasing an additional 1,145,698 shares during the last quarter. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Insider Activity at Tempus AI

In other news, CEO Eric P. Lefkofsky sold 187,655 shares of the business’s stock in a transaction that occurred on Wednesday, December 18th. The shares were sold at an average price of $37.54, for a total transaction of $7,044,568.70. Following the completion of the sale, the chief executive officer now owns 9,557,283 shares in the company, valued at approximately $358,780,403.82. The trade was a 1.93 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Bradley A. Keywell sold 395,800 shares of the company’s stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $42.95, for a total transaction of $16,999,610.00. Following the completion of the transaction, the insider now owns 16,164,449 shares of the company’s stock, valued at approximately $694,263,084.55. The trade was a 2.39 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 845,041 shares of company stock worth $35,125,473.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on TEM shares. Piper Sandler reiterated a “neutral” rating and set a $70.00 price objective (up from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Stifel Nicolaus cut shares of Tempus AI from a “buy” rating to a “hold” rating and increased their target price for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Loop Capital upped their price objective on shares of Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research note on Tuesday, October 15th. Bank of America boosted their target price on Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a report on Friday, December 13th. Finally, Guggenheim assumed coverage on Tempus AI in a report on Monday, December 9th. They issued a “buy” rating and a $74.00 price target for the company. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $56.00.

Tempus AI Stock Up 7.2 %

TEM stock traded up $2.74 during midday trading on Monday, hitting $40.99. The company’s stock had a trading volume of 2,965,889 shares, compared to its average volume of 3,596,364. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $79.49. The firm has a 50-day simple moving average of $48.93 and a 200-day simple moving average of $46.86. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.